AJMC October 6, 2024
Key Takeaways
- AI and digital technologies can revolutionize COPD diagnosis and treatment, enhancing diagnostic accuracy and therapy adherence.
- The unregulated mobile health app market risks promoting non-evidence-based interventions, potentially distracting from proven treatments.
- Digital inhalers improve adherence but have not significantly impacted patient outcomes; affordability and education are crucial.
- Digital technologies effectively deliver pulmonary rehabilitation, especially in resource-limited settings, but guidance on program selection is lacking.
- Clinicians must address digital inequities, ensure diverse training data, and bridge the evidence gap to optimize patient care.
Caroline Quill, MD, associate professor of medicine at the University of Rochester Medical Center, discussed how artificial intelligence (AI) and digital technologies could revolutionize chronic obstructive pulmonary disease (COPD) diagnosis and treatment at the...
Today's Sponsors
Today's Sponsor